Inositol phospholipid (IP) species are membrane-bound signaling molecules that have been implicated in almost all aspects of cellular physiology, including metabolism, cellular growth, survival and proliferation. Therefore it is not surprising that disruptions within this key signaling pathway have been linked to conditions as diverse as inflammatory disease, cancer, diabetes and obesity.
Inositol Phospholipid Signaling in Physiology and Disease 2012 is a conference that bridges the divide between clinical and basic research in different therapeutic areas and provides the latest therapeutic approaches for targeting this pathway through emerging methods of pharmaceutical modulation.
Investigators working on the specificity and interplay of diverse IP-modifying enzymes (e.g. PTEN, PI3K, INPP4A/B and SHIP1/2) in the context of both normal physiology and disease.
